Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Safedin Beqaj

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The Journal of Molecular Diagnostics : JMD|April 27, 2024
EarlyTect BCD, a Streamlined PENK Methylation Test in Urine DNA, Effectively Detects Bladder Cancer in Patients with HematuriaBo-Ram Bang, Jin Zhong, Tae Jeong Oh, et al.
European Urology Oncology|October 2, 2020
Validation of an mRNA-based Urine Test for the Detection of Bladder Cancer in Patients with HaematuriaFranciscus Johannes P van Valenberg, Andrew M Hiar, Ellen Wallace, et al.
European Urology|December 17, 2018
Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder CancerF Johannes P van Valenberg, Andrew M Hiar, Ellen Wallace, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The Journal of Molecular Diagnostics : JMD|April 27, 2024
EarlyTect BCD, a Streamlined PENK Methylation Test in Urine DNA, Effectively Detects Bladder Cancer in Patients with HematuriaBo-Ram Bang, Jin Zhong, Tae Jeong Oh, et al.
European Urology Oncology|October 2, 2020
Validation of an mRNA-based Urine Test for the Detection of Bladder Cancer in Patients with HaematuriaFranciscus Johannes P van Valenberg, Andrew M Hiar, Ellen Wallace, et al.
European Urology|December 17, 2018
Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder CancerF Johannes P van Valenberg, Andrew M Hiar, Ellen Wallace, et al.
Pageof 2